tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Luca Issi, 123 are a HOLD (35.96%), 219 are a BUY (64.04%).
Analyst Luca Issi, currently employed at RBC, carries an average stock price target met ratio of 55.34% that have a potential upside of 44% achieved within 209 days.
Luca Issi’s has documented 666 price targets and ratings displayed on 36 stocks. The coverage is on Healthcare, Communication Services, Technology sectors.
Most recent stock forecast was given on BMRN, Biomarin Pharmaceutical.
Analyst best performing recommendations are on NTLA (INTELLIA THERAPEUTICS).
The best stock recommendation documented was for NTLA (INTELLIA THERAPEUTICS) at 6/28/2021. The price target of $150 was fulfilled within 1 day with a profit of $16.57 (12.42%) receiving and performance score of 124.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Aug-2026
$6
$4.82 (408.47%)
$5
2 months 18 days ago
(17-Aug-2026)
1/10 (10%)
$3.92 (188.46%)
148
Buy Since 15-Apr-2026
$10
$8.5 (566.67%)
$10
6 months 14 days ago
(22-Apr-2026)
0/2 (0%)
$7.61 (318.41%)
Sell Since 16-Apr-2026
6 months 19 days ago
(16-Apr-2026)
0/3 (0%)
$2.86 (55.64%)
Buy Since 04-Apr-2023
$11
$9.82 (832.20%)
$12
6 months 19 days ago
(16-Apr-2026)
0/12 (0%)
$8.63 (364.14%)
Hold Since 21-Mar-2023
$3.85
$2.67 (226.27%)
$6
6 months 21 days ago
(14-Apr-2026)
1/2 (50%)
$1.57 (68.86%)
44
Which stock is Luca Issi most bullish on?
Which stock is Luca Issi most reserved on?
What Year was the first public recommendation made by Luca Issi?
